HSBC analyst Jeremy Fialko downgraded Haleon (HLN) to Hold from Buy with a 420 GBp price target See what stocks are receiving Strong Buy ratings from top-rated analysts. Filter, analyze ...

February 27, 2025 Sensodyne maker Haleon says 2025 revenue growth skewed to second half British consumer healthcare group Haleon on Thursday said 2025 revenue and profit growth would be weighted ...

GSK's consumer health spinout Haleon started trading on the London Stock Exchange this morning, making its debut with a price of 330 pence and a market valuation of around £31 billion ($37 billion).

Haleon had a net margin of 10.85% and a return on equity of 14.76%. The company had revenue of $3.54 billion during the quarter, compared to analysts’ expectations of $3.38 billion.

In this article, we are going to take a look at where Haleon plc (NYSE:HLN) stands against the other pharma stocks. Healthcare, which includes numerous businesses that offer patient care ...

British consumer healthcare group Haleon disappointed investors on Thursday after the Sensodyne toothpaste maker said 2025 revenue growth would be weighted to the second half of the year ...